Fig. 2From: Association of the ward pharmacy service with active implementation of therapeutic drug monitoring for vancomycin and teicoplanin—an epidemiological surveillance study using Japanese large health insurance claims databaseComparison of the proportions of TDM implementation for each anti-MRSA agent before and after propensity score matching. Proportions of TDM implementation were compared by Chi-squared test. P value of ≤0.05 was considered statistically significant. TDM: therapeutic drug monitoring, VCM: vancomycin, TEIC: teicoplanin, ABK: arbekacinBack to article page